Clin2
NCT07172100Worth exploringEnrolling by invitation

Papaya Leaf Extract for Kids with Dengue and Low Platelets

Dengue FeverPapaya Leaf ExtractPediatric Patients

Part of Infections clinical trials.

This trial tests if papaya leaf extract can help raise low platelet counts in young children with dengue fever. It may offer a natural way to reduce the risk of bleeding.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
2 years to 12 years
Study type
Interventional

Who can take part

  • You must have dengue fever.
  • The patient should be between 2 months and 2 years old.
  • You cannot be allergic to papaya leaf extract.
  • You cannot have a bleeding disorder.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06843226Recruiting
Dengue vaccine study for children and teens

This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.

Banjarmasin, South Kalimantan
NCT07409857Recruiting
Dengue infection in congenital bleeding disorders registry

This study creates a registry to track how dengue infection affects people with congenital bleeding disorders, such as hemophilia. It aims to learn more about managing dengue in this group.

Bangkok
NCT06665035Recruiting· Phase 3
Dengue vaccine study for infants and toddlers

This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.

Barranquilla, Atlántico
NCT07007585Recruiting
Dengue care: who needs hospital or transfusion?

This study looks at why some people with dengue need to be hospitalized or get a blood transfusion. It aims to make care safer and help doctors know who needs closer monitoring.

Piedras Negras, Coahuila
NCT06917001Not yet recruiting· Phase 2
Testing Resomelagon for dengue fever

This trial tests whether a new medicine called Resomelagon can safely treat dengue fever. It looks at how well the medicine works and if it helps you recover faster.

Belo Horizonte, Minas Gerais
NCT06006559Recruiting· Phase 2
Testing a new dengue treatment (EYU688) in adults

This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.

Manaus, Amazonas

Hear when a new Dengue Fever trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.